BPC-157

BPC-157 is a synthetic peptide fragment marketed for tendon, muscle and gut healing. Its evidence base is almost entirely rodent studies. There are no adequately sized published randomised human trials, it is not approved for human use, and the FDA has assessed it in the compounding context with safety concerns identified.

An evidence-first review of BPC-157: animal research, the near-total absence of human trials, FDA compounding restrictions, and the risks of grey-market supply.

The most confidently marketed healing peptide, and one of the least studied in humans.

Key takeaways

Why the animal literature looks so strong

Rodent studies report BPC-157 helping almost every tissue tested. Read optimistically, that suggests a broad cytoprotective mechanism. Read carefully, it is a warning sign: compounds that appear to fix everything in one laboratory's hands usually narrow sharply under independent, blinded replication - and much of this literature has not been independently replicated.

The human evidence gap

There is no published randomised controlled trial of adequate size establishing that BPC-157 accelerates healing in people. That is not a technicality. It means the central marketing claim has never been tested in the population it is sold to. The first randomised human trial, a Phase 2 study in acute hamstring strain (NCT07437547), began recruiting in February 2026; its results are not yet available.

Supply and regulatory reality

Every vial sold online sits outside pharmaceutical manufacturing oversight. Independent testing of grey-market peptides has repeatedly found incorrect potency, wrong compounds and non-sterile preparations. The FDA has separately assessed BPC-157 in the compounding context with safety concerns identified - verify the current status on the FDA's compounding pages.

Beiing does not publish dosages, schedules, administration instructions, combinations or sourcing guidance for this or any other compound.

If you are dealing with an injury

The interventions with real clinical evidence are less exciting and considerably better supported.

Frequently asked questions

Is BPC-157 legal?

In the U.S., since 28 October 2026, a licensed pharmacist or physician can compound it for an individual patient with a prescription under an interim HHS policy. It is still not approved as a medicine, 'research use only' products sold online are not legal to sell for use in people, and it is banned in competitive sport. Rules differ in other countries.

Does oral BPC-157 work?

Oral claims add a second unproven assumption - meaningful absorption - to an already unproven effect. Human pharmacokinetic data is lacking.

Why do so many people say it worked for them?

Most soft tissue injuries improve over time regardless, people usually change several things at once, expectation effects are strong for pain, and people who saw no benefit rarely post about it.

Related on Beiing

Sources

  1. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (Federal Register document 2026-22192, docket HHS-OASH-2026-0496) - U.S. Department of Health and Human Services, via the Federal Register
  2. FDA - Bulk Drug Substances Used in Compounding Under Section 503A - U.S. Food and Drug Administration
  3. FDA - Human Drug Compounding - U.S. Food and Drug Administration
  4. BPC-157: What athletes should know about the prohibited experimental peptide - U.S. Anti-Doping Agency (USADA)
  5. BPC-157 for acute hamstring strain, NCT07437547 - ClinicalTrials.gov, U.S. National Library of Medicine
  6. AP report: FDA scientists opposed the move to ease peptide access - Associated Press, via PBS NewsHour
  7. Use of untested 'Wolverine' peptide on the rise, study finds (September 2026) - Reuters, via CTV News
  8. PubMed - National Library of Medicine - NIH

Written by Beiing Editorial Team · Editorially reviewed by Research & Regulatory Review Desk · Published · Last reviewed . Editorial and research review by Beiing writers and researchers. This is not medical or clinical review, and no clinician signs off on our content.

Educational content only - not medical advice. In a crisis, call or text 988 (US) or your local emergency number. See crisis resources.